We Make Life Count
Over 25 years of cutting-edge research in life-saving vaccines and infectious diseases
The Vaccines and Infectious Diseases Analytics (“VIDA”) Research Unit of the University of the Witwatersrand (“Wits”), is an African-led research unit that combines clinical, microbiological and epidemiological expertise to deliver scientific breakthroughs in the field of vaccines and infectious diseases. We strive to make a meaningful difference to the communities around us, as well as at a global level through pioneering work led by accomplished teams.
Research Focus Areas
Wits VIDA’s current focus areas include next-generation vaccines against rotavirus and TB, as well as development of novel vaccines targeted at pregnant women to protect their young infants against the leading causes of sepsis and pneumonia.
-
Epidemiology & vaccines against Group B streptococcus disease
Identifying protein antigens common to most GBS invasive isolates with potential to be developed into vaccines.
-
Influenza Epidemiology & Influenza Vaccines
This research aims to identify protein antigens common to most GBS invasive isolates with potential to be developed into vaccine candidates.
-
Risk Factors, incl. impact of the Vaginal Microbiome, on Fetal Outcomes
Impact of the vaginal microbiome on risk of poor obstetric outcome, and risk for early-onset sepsis in the neonate.
-
Epidemiology & Prevention of Pneumococcal Disease
Wits VIDA was pivotal in the introduction of the PCV into the South African National EPI.
-
Child Health & Mortality Program on Surveillance
Saving children’s lives by collecting, analysing, and sharing data about the causes of child mortality in regions where it is highest.
-
Epidemiology & Prevention of Pneumonia Morbidity & Sequelae in Children
Pneumonia still remains a leading cause of hospitalization and death among children in SA and globally.
-
Prevention of Diarrheal Disease
Following research by the unit, SA was the first African country to introduce the rotavirus vaccine into a public immunization program.
-
Immunity in HIV-Exposed & HIV-Uninfected Children
Study on the immune mediators which might contribute to HIV-exposed uninfected infants (HEUs) having a higher incidence of severe infections.
-
Covid Epidemiology in South Africa
Study on the immune mediators which might contribute to HIV-exposed uninfected infants (HEUs) having a higher incidence of severe infections.
